Teva Says Rival Hoarding Drug To Slow Generic Development
A Teva Pharmaceuticals subsidiary on Tuesday accused Amicus Therapeutics Inc. of hoarding supplies of a costly brand-name medication, in violation of a new federal law aimed at providing generic-drug makers with...To view the full article, register now.
Already a subscriber? Click here to view full article